COGNITION THERAPEUTICS INC·4

Nov 16, 8:31 AM ET

Ricciardi Lisa 4

4 · COGNITION THERAPEUTICS INC · Filed Nov 16, 2022

Insider Transaction Report

Form 4
Period: 2022-11-15
Ricciardi Lisa
DirectorCEO & President
Transactions
  • Purchase

    Common Stock

    2022-11-15$1.30/sh+12,000$15,60024,500 total
Footnotes (1)
  • [F1]Represents the weighted average purchase price of $1.297. These shares were acquired in multiple transactions ranging from $1.285 to $1.300 rounded to the nearest thousandth. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission, Cognition Therapeutics, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES